Top

Gepubliceerd in:

01-12-2002 | Artikelen

Medicamenteuze behandeling van angststoornissen bij kinderen en adolescenten

Auteurs: Ann O. P. Steppe, Robert F. Ferdinand

Gepubliceerd in: Kind en adolescent | Uitgave 4/2002

Samenvatting

in dit artikel wordt een overzicht gegeven van de effectiviteit van medicatie bij negen gerandomiseerde dubbelblind placebogecontroleerde studies bij gegeneraliseerde angststoornis, separatieangststoornis en sociale fobie op de kinder- en jeugdleeftijd. Een aantal problemen die men tegenkomt bij deze medicamenteuze behandeling zal worden besproken. Enerzijds zullen we naar voren brengen voor welke problemen leeftijdsspecifieke aspecten van farmacodynamiek en kinetiek ons stellen. Anderzijds zal besproken worden welke moeilijkheden we tegenkomen bij de interpretatie van de resultaten van deze studies en wordt er gekeken naar welke handvatten deze studies ons bieden voor de klinische praktijk.

vorige artikel Angststoornissen bij kinderen: genetische en gezinsinvloeden

volgende artikel Interventie- en preventieve programma’s voor angst en depressie

American Psychiatric Association (1980). Diagnostic and statistical manual of mental disorders (3rd ed.). Washington DC: American Psychiatric Association.

American Psychiatric Association (1987). Diagnostic and statistical manual of mental disorders (3rd ed. rev.). Washington DC: American Psychiatric Association.

American Psychiatric Association (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington DC: American Psychiatric Association.

Anderson, J. C., Williams, S., McGee, R., & Silva, P. A. (1987). DSM-III disorders in preadolescent children. Prevalence in large sample from the general population. Archives of General Psychiatry, 44, 69-76.PubMed

Antonini, A., & Leenders, K. L. (1993). Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and (11C)-raclopride. Annals of the New York Academy of Scienes, 24, 81-85.CrossRef

Beck, A. T., Rush, A. J., Shaw, B. F., & Emery, G. (1979). Cognitive therapy for depression. New York: Guilford.

Beitchman, J. H., Raman, S., Carlson, J., Clegg, M., & Kruidenier, B. (1985). The development and validation of the children’s self-report psychiatric rating scale. Journal of the American Academy of Child and Adolescent Psychiatry, 24, 413-428.CrossRef

Berney, T., Kolvin, I., Bhate, S. R., Garside, R. F., Jeans, J., Kay, B., & Scarth, L. (1981). School phobia: a therapeutic trial with clomipramine and short-term outcome. British Journal of Psychiatry, 138, 110-118.CrossRefPubMed

Bernstein, G. A., Borchardt, C. M., Perwien, A. R., Crosby, R. D., Kushner, M. G., Thuras, P. D., & Last, C. G. (2000). Imipramine plus cognitive-behavioral therapy in the treatment of school refusal. Journal of American Child and Adolescence Psychiatry, 39, 276-283.CrossRef

Bernstein, G. A., Crosby, R. D., Perwien, A. R., & Borchardt, C. M. (1996). Anxiety rating for children-revised: reliability and validity. Journal of Anxiety Disorders, 10, 97-114.CrossRef

Bernstein, G. A., Garfinkel, B. D., & Borchardt, C. M. (1990). Comparative studies of pharmacotherapy for school refusal. Journal of American Child and Adolescence Psychiatry, 29, 773-781.

Bourin, M., & Couetoux du Tertre, A. (1992). Pharmacokinetics of psychotropic drugs in children. Clinical Neuropharmacology, 15 (S1), PT A: 224A-225A.PubMed

Bowen, R. C., Offord, D. R., & Boyle, M. H. (1990). The prevalence of overanxious disorder and separation anxiety disorder: Results from the Ontario child health study. Journal of the American Academy for Child and Adolescent Psychiatry, 29, 753-758.CrossRef

Conners, C. K. (1973). Rating scales for use in drug studies with children. Psychopharmacology Bulletin, (Special Issue), 24-29.

Costello, E. J. (1989). Child Psychiatric Disorders and Their Correlates: A primary care pediatric sample. Journal of the American Child and Adolescent Psychiatry, 28, 851-855.

Costello, E. J., Angold, A., & Keeler G. P. (1999). Adolescent outcomes of childhood disorders: the consequences of severity and impairment. Journal of the American Academy of Child and Adolescence Psychiatry, 38, 121-128.CrossRef

Gittelman, R. (1985a). Teacher rating scale (modified Conners): anxiety and mood items added. Psychopharmacology Bulletin (Special feature), 21, 945-948.

Gittelman, R. (1985b). Parent’s questionnaire (modified Conners): anxiety and mood items added. Psychopharmacology Bulletin (Special feature), 21, 939-943.

Gittelman, R. (1985c). Children’s Manifest Anxiety Scale: Parent Ratings. Psychopharmacology Bulletin (Special feature), 21, 934-935.

Gittelman, R. (1985d). Children’s Manifest Anxiety Scale: Child’s ratings. Psychopharmacology Bulletin (Special feature), 21, 936-937.

Gittelman-Klein, R., Klein, D. F., & Oaks, G. (1971). Controlled imipramine treatment of school phobia. Archives of General Psychiatry, 25, 204-207.

Gottfries, C. G., Roos, R. E., & Winblad, B. (1974). Determination of 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and homovanillic acid in brain tissue from an autopsy material. Acta Psychiatrica Scandinavica, 50, 496-507.CrossRefPubMed

Graae, F., Milner, J., Rizzotto, L., & Klein, R. G. (1994). Clonazepam in childhood anxiety disorders. Journal of American Child and Adolescence Psychiatry, 33, 372-376.CrossRef

Guy, W. (1976). ECDEU Assessment Manual for Psychopharmacology: publication ADM 7-38 (pp. 218-222). Washington, DC, US Department of Health, Education, and Welfare.

Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50-55.PubMed

Hamilton, M. (1960). A rating scale for depression. Journal of Neurology Neurosurgery Psychiatry, 23, 56-62.CrossRef

Hughes, C., & Preskorn, S. H. (1989). Depressive symptoms in children and adolescents: diagnosis and treatment. Annals of Clinical Psychiatry, 1, 109-118.CrossRef

Jensen, P. S., Bhatara, V. S., Vitiello, B., Hoagwood, K., Feil, M., & Burke, L. B. (1999). Psychoactive medication prescribing practices for U.S. children: Gaps between research and clinical practice. Journal of American Aacademy of Child and Adolescence Psychiatry, 38, 557-565.CrossRef

Kashani, J. H., & Orvaschel, H. (1990). A community study of anxiety in children and adolescents. The American Journal of Psychiatry, 147, 313-318.PubMed

Kendall, P. C. (1994). Treating anxiety disorders in children: results of a randomised clinical trial. Journal of Consult Clinical Psychology, 62, 100-110.CrossRef

Klein, R. G., Koplewicz, H. S., & Kanner, A. (1992). Imipramine treatment of children with separation anxiety disorder. Journal of American Child and Adolescence Psychiatry, 31, 21-28.CrossRef

Kovacs, M., & Beck, A. (1977). An empirical-clinical approach toward a definition of childhood depression. In J. G. Schulterbrandt, & A. Raskin (Red.), Depression in childhood (pp. 1-25). New York: Raven Press.

Kutcher, S. P., Reiter, S., Gardner, D. M., & Klein, R. G. (1992). The pharmacotherapy of anxiety disorders in children and adolescents. Psychiatric Clinics of North America, 15, 41-67.PubMed

Lake, C. R., Ziegler, M. G., & Kopin, I. J. (1976). Use of plasma norepinephrine for evaluation of sympathetic neuronal function in man. Life Science, 18, 1315-1325.CrossRef

Lang, M., & Tisher, M. (1978). Children’s depression scale. Melbourne: Australian Council for Educational Research.

Leonard, H. L., March, J., Rickler, K. C., & Allen, A. J. (1997). Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents. Journal of American Child and Adolescence Psychiatry, 36, 725-736.CrossRef

March, J. S., Parker, J. D. A., Sullivan, K., Stallings, P., & Conners, K. (1997). The multidimensional anxiety scale for children (MASC): factor strucure, reability, and validity. Journal of the American Academy for Child and Adolescent Psychiatry, 36, 554-565.CrossRef

Marshall, W. A., & Tanner, J. M. (1969). Variations in the pattern of pubertal changes in girls. Archives of Diseases in Childhood, 44, 291-303.CrossRef

Marshall, W. A., & Tanner, J. M. (1970). Variations in the pattern of pubertal changes in boys. Archives of Diseases in Childhood, 45, 13-23.CrossRef

Overall, J., & Pfefferbaum, B. (1982). Brief reports and reviews: the brief psychiatric rating scale for children.Psychopharmacol Bulletin, 18, 10-16.

Pine, D. S., Cohen, P., Gurley, D., Brook, J., & Ma, Y. (1998). The risk for early-adulthood anxiety and depressive disorders in adolescents with anxiety and depressive disorders. Archives of General Psychiatry, 55, 56-64.

Poznanski, E. O., Freeman, L. N., & Mokros, H. B. (1985). Children’s depression rating scale-revised Psychopharmacology Bulletin, 21, 979-989.

Rane, A., & Wilson, J. T. (1976). Clinical pharmacokinetics in infants and children. Clinical Pharmacokinetics, 1, 2-24.CrossRefPubMed

Reich, W., & Welner, Z. (1990). Diagnostic interview for children and adolescents-revised-child version and diagnostic interview for children and adolescents-revised parent version. Sint Louis: Washington University Division of Child Psychiatry.

Reynolds, C. R., & Richmond, B. O. (1978). What I think and feel: a revised measure of children’s manifest anxiety. Journal of Abnormal Child Psychology, 6, 271-280.CrossRefPubMed

Reynolds, C. R., & Richmond, B. O., (1984). Revised children’s manifest anxiety scale. Los Angeles, CA: Western Psychological Services.

Ritvo, E. R., Yuweler, A., & Geller, E. (1971). Maturational changes in blood serotonin levels and platelet count. Biochemical Medicine, 5, 90-96.CrossRefPubMed

Rynn, M. A., Siqueland, L., & Rickels, K. (2001). Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. The American Journal of Psychiatry, 158, 2008-2014.CrossRefPubMed

Seeman, P., Bzowej, N. H., Guan, H. C., Bergeron, C., Becker, L. E., Reynolds, G. P., Bird, E. D., Riederer, P., Jellinger, K., & Watanabe, S. (1987). Human brain dopamine receptors in children and aging adults. Synapse, 1, 399-404.CrossRefPubMed

Shaffer, D., Gould, M. S., & Brasic, J. (1983). A children’s global assessment scale (CGAS). Archives of General Psychiatry, 40, 1228-1231.PubMed

Shaffer, D., Fischer, P., Piacentini, J., Schwab-Stone, M., & Wicks, J. (1989). Diagnostic interview schedule for children (DISC 2.1). New York: Division of child and adolescent psychiatry, New York State Psychiatric Institute.

Shaffer, D., Fisher, P., Dulcan, M. K., Davies, M., Piacentini, J., Schwab-Stone, M. E., Lahey, B. B., Bourdon, K., Jensen, P. S., Bird, H. R., Canino, G., & Regier, D. A. (1996). The NIMH diagnostic interview schedule for children version 2.3 (DISC 2.3): description, acceptability, prevalence rates, and performance in the MECA study. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 865-877.PubMedCrossRef

Shortt, A. L., Barrett, P. M., & Fox, T. L. (2001). Evaluating the FRIENDS program: a cognitive-behavioral group treatment for anxious children and their parents. Journal of Clinical Child Psychology, 30, 525-535.CrossRefPubMed

Simeon, J. G., Ferguson, H. B., Knott, V., Roberts, N., Gauthier, B., Dubois, C., & Wiggins, D. (1992). Clinical, cognitive, and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. Journal of American Child and Adolescence Psychiatry, 31, 29-33.CrossRef

Spielberger, C. D. (1973). Manual for the state-trait anxiety inventory for children. Palo Alto, CA: Consulting Psychologists Press, Inc.

Tosyali, M. C., & Greenhill, L. L. (1998). Child and adolescent psychopharmacology: Important developmental issues. Pediatric Clinics of North America, 45, 1021-1035.CrossRefPubMed

Vitiello, B., & Jensen, P. S. (1995). Developing clinical trials in children and adolescents. Psycho-pharmacology Bulletin, 31, 75-81.

Walkup, J., & Davies, M. (1999). The pediatric anxiety rating scale (PARS): A reliability study. In Scientific proceedings of the 46^th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, Chicago, October 19-24. NR 78 abstract.

Walkup, J. T., Labellarte, M. J., Riddle, M. A., Pine, D. S., Greenhill, L., Klein, R., Davies, M., Sweeney, M., Abikoff, H., Hack, S., Klee, B., McCracken, J., Bergman, L., Piacentini, J., March, J., Compton, S., Robinson, J., O’Hara, T., Baker, S., Vitiello, B., Ritz, L., & Roper, M. (2001). Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The New England Journal of Medicine, 344, 1279-1285.CrossRef

Whitaker, A., Johnson, J., Shaffer, D., Rapoport, J.L., Kalilow, K., Walsh, B. T., Davies, M. Braiman, S., & Dolinsky, A. (1990). Uncommon troubles in young people: prevalence estimates of selected psychiatric disorders in a nonreferred adolescent population. Archives of General Psychiatry, 47, 487-496.PubMed

Titel: Medicamenteuze behandeling van angststoornissen bij kinderen en adolescenten
Auteurs: Ann O. P. Steppe
Robert F. Ferdinand
Publicatiedatum: 01-12-2002
Uitgeverij: Bohn Stafleu van Loghum
Gepubliceerd in: Kind en adolescent / Uitgave 4/2002
Print ISSN: 0167-2436
Elektronisch ISSN: 1876-5998
DOI: https://doi.org/10.1007/BF03060859

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Samenvatting

Log in om toegang te krijgen

Andere artikelen Uitgave 4/2002

Angststoornissen bij kinderen en jeugdigen

De nieuwe kleren van de keizer!?

Gedragstherapeutische en cognitieve interventies bij kinderen met angststoornissen

Nieuwe diagnostiek van angststoornissen bij kinderen en jeugdigen

De diagnostische validiteit van angststoornissen bij kinderen en adolescenten

Systeemtherapeutische interventies bij kinderen met angststoornissen